PCA
ELV icon

Pallas Capital Advisors’s Elevance Health ELV Stock Holding History

Pallas Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
1,273
+195
+18% +$72.3K 0.02% 574
2026
Q1 		$316K Sell
1,078
-1,771
-62% -$582K 0.01% 624
2025
Q4 		$999K Sell
2,849
-94
-3% -$31.8K 0.03% 357
2025
Q3 		$951K Buy
2,943
+2,343
+391% +$729K 0.04% 356
2025
Q2 		$234K Sell
600
-2,988
-83% -$1.2M 0.01% 725
2025
Q1 		$1.56M Buy
+3,588
New +$1.44M 0.06% 221
2022
Q2 		– Sell
-420
Closed -$217K – 234
2022
Q1 		$217K Sell
420
-166
-28% -$75.9K 0.03% 223
2021
Q4 		$259K Buy
586
+68
+13% +$28.6K 0.03% 269
2021
Q3 		$220K Buy
+518
New +$197K 0.02% 357

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pallas Capital Advisors's ELV Position: Q2 2026 in Review

Pallas Capital Advisors increased its Elevance Health (ELV) stake by 18% in Q2 2026, buying an estimated $72.3K and bringing the position to 1,273 shares worth $493K. The position accounts for 0.02% of the portfolio, ranked #574.

Pallas Capital Advisors first reported a position in ELV in Q3 2021 and has held it in 9 quarters since. The position peaked at $1.56M in Q1 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Pallas Capital Advisors held 1,273 shares of Elevance Health worth $493K as of Q2 2026.
  • Pallas Capital Advisors bought 195 Elevance Health shares in Q2 2026, an estimated $72.3K.
  • Elevance Health made up 0.02% of Pallas Capital Advisors's portfolio in Q2 2026, its #574 holding.
  • Pallas Capital Advisors first reported a position in Elevance Health in Q3 2021 and has held it in 9 quarters since.
  • Pallas Capital Advisors's Elevance Health position peaked at $1.56M in Q1 2025.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.